Mavacamten
|
玛伐凯泰
|
1642288-47-8
|
BC-DXI-843
|
化合物BC-DXI-843
|
2421117-98-6
|
Propargylcholine
|
N-(2-羟乙基)-N,N-二甲基-2-丙炔-1-溴化铵
|
111755-76-1
|
T-26c
|
T-26c
|
869296-13-9
|
USP25/28 inhibitor AZ1
|
化合物AZ1
|
2165322-94-9
|
FT113
|
FT113
|
1630808-89-7
|
Dazoxiben
|
UK-37248
|
74226-22-5
|
AZD5153
|
AZD5153结晶体(API形式)
|
1869912-40-2
|
ONC206
|
ONC206
|
1638178-87-6
|
1-Piperazinecarboxylic acid, 4-[3-amino-6-(2-hydroxyphenyl)-4-pyridazinyl]-, 1,1-dimethylethyl ester
|
化合物SGC-SMARCA-BRDVIII
|
1997319-84-2
|
4-[(5,6,7,8-TETRAHYDRO-5,5,8,8-TETRAMETHYL-2-NAPHTHALENYL)CARBOXAMIDO]BENZOIC ACID
|
4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)甲酰氨基]苯甲酸
|
102121-60-8
|
LIT-001
|
化合物LIT-001
|
2245072-21-1
|
Octanoic acid, 8-[(2-hydroxyethyl)[6-oxo-6-(undecyloxy)hexyl]amino]-, 1-octylnonyl ester
|
SM-102
|
2089251-47-6
|
GNE-617
|
N-[[4-[(3,5-二氟苯基)磺酰基]苯基]甲基]咪唑并[1,2-A]吡啶-6-甲酰胺
|
1362154-70-8
|
1H-Pyrazole-1-acetamide, N-methyl-N-[2-(4-methylphenoxy)ethyl]-4-[(1-oxo-3-phenoxypropyl)amino]-
|
1H-Pyrazole-1-acetamide, N-methyl-N-[2-(4-methylphenoxy)ethyl]-4-[(1-oxo-3-phenoxypropyl)amino]-
|
1185329-96-7
|
SR8278
|
SR8278;SR-8278;SR 8278
|
1254944-66-5
|
4-Ethyl-5-methyl-5,6-dihydro-[1,3]dioxolo[4,5-j]phenanthridine
|
化合物HLY78
|
854847-61-3
|
SC-43
|
SC-43
|
1400989-25-4
|
CNQX
|
6-氰基-7-硝基喹喔啉-2,3-二酮
|
115066-14-3
|
Benzeneacetamide, 2-[2-[2-[[2-methoxy-4-(1-methyl-4-piperidinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]ethyl]-
|
AMP-945
|
1393653-34-3
|
ML355
|
ML355
|
1532593-30-8
|
AMG-009
|
1027847-67-1
|
1027847-67-1
|
KKL-35
|
865285-29-6
|
865285-29-6
|
9H-INDENO[1,2-B]PYRAZINE-2,3-DICARBONITRILE, 9-[(PHENYLMETHOXY)IMINO]-
|
9-[(苯甲氧基)肟]-9H-茚并[1,2-B]吡嗪-2,3-二甲腈
|
924296-18-4
|
NAcM-OPT
|
化合物NACM-OPT
|
2089293-61-6
|
MAC-545496
|
MAC-545496
|
838810-96-1
|
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-
|
2-Pyridinecarboxamide, N-[4-[[3-[(1-oxo-2-propen-1-yl)amino]benzoyl]amino]phenyl]-6-(1H-pyrazol-3-yl)-
|
2227368-54-7
|
2-Pyrazinemethanol, 6-[(2-amino-3-chloro-4-pyridinyl)thio]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]dec-8-yl]-5-methyl-
|
RMC-4630
|
2172652-48-9
|
ETC-159
|
1,2,3,6-四氢-1,3-二甲基-2,6-二氧代-N-(6-苯基-3-哒嗪基)-7H-嘌呤-7-乙酰胺
|
1638250-96-0
|
Mebeverine hydrochloride
|
盐酸麦皮凡林
|
2753-45-9
|
T-26c
|
HIF-1 INHIBITOR-1
|
2380261-53-8
|
DXd
|
DX-8951衍生物
|
1599440-33-1
|
2-[1-(6-chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonylindol-3-yl]ethanamine;hydrochloride 1H-Indole-3-ethanamine, 1-((6-chloroimidazo((2,1-b)thiazol-5-yl)sulfonyl)-, hydrochloride (1:1)
|
2-[1-[(6-Chloroimidazo[2,1-b][1,3]thiazol-5-yl)sulfonyl]-1H-indol-3-yl]ethylamine Hydrochloride
|
554403-08-6
|
1-((1-(2-aminopyrimidin-4-yl)-2-((2-methoxyethyl)amino)-1H-benzo[d]imidazol-6-yl)ethynyl)cyclohexanol
|
GNE-2861
|
1394121-05-1
|
RET V804M-IN-1
|
化合物RET V804M-IN-1
|
2414909-94-5
|
VUF11207
|
VUF11207
|
1378524-41-4
|
ASP7663
|
ASP 7663;ASP-7663;ASP7663
|
1190217-35-6
|
SLV-2436
|
2095704-43-9
|
2095704-43-9
|
Src Inhibitor 3
|
Src Inhibitor 3
|
2380027-49-4
|
Carbamic acid, N-[5-[2-(acetylamino)-6-benzothiazolyl]-2-methyl-3-pyridinyl]-, cyclohexyl ester
|
PK68
|
2173556-69-7
|
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)-
|
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)-
|
1998705-62-6
|
4,4,5,5-Tetramethyl-2-(3-methylbenzo[b]thiophen-2-yl)-1,3,2-dioxaborolane
|
4,4,5,5-四甲基-2-(3-甲基苯并[B]噻吩-2-基)-1,3,2-二氧硼烷
|
1072811-91-6
|
SR-717
|
SR-717
|
2375421-09-1
|
ML327
|
1883510-31-3
|
1883510-31-3
|
Ritanserin
|
利坦丝林
|
87051-43-2
|
5H-Pyrazolo[4,3-c]pyridine-5-carboxamide, 3-[7-(difluoromethyl)-3,4-dihydro-6-(1-methyl-1H-pyrazol-4-yl)-1(2H)-quinolinyl]-1-[1-[15-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]amino]-1-oxo-4,7,10,13-tetraoxapentadec-1-yl]-4-piperidinyl]-1,4,6,7-tetrahydro-N-methyl-
|
化合物DCBP-1
|
2484739-25-3
|
ATP synthase inhibitor 1
|
ATP SYNTHASE INHIBITOR 1
|
1023043-30-2
|
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF
|
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF
|
2097117-06-9
|
(S)-2-(6,7-DIHYDRO-5H-THIAZOLO[4,5-F]INDOL-2-YL)-4,5-DIHYDROTHIAZOLE-4-CARBOXYLIC ACID
|
CYCLUC1
|
1247879-16-8
|
WWL70
|
947669-91-2
|
947669-91-2
|
Olumacostat Glasaretil
|
OLUMACOSTAT GLASARETIL; DRM01B; DRM-01B; DRM 01B.
|
1261491-89-7
|
AP 20187
|
AP 20187
|
195514-80-8
|
7-DICHLORO-2-DIMETHYLAMINOMETHYL-QUINOLIN-8-OL
|
化合物PBT-1033
|
747408-78-2
|
8-benzyl-2-(furan-2-ylmethyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one
|
Furimazine
|
1374040-24-0
|
Val-cit-PAB-OH
|
VAL-CIT-PAB
|
159857-79-1
|
CDPPB
|
3-氰基-N-(1,3-二苯基吡唑-5-基)苯甲酰胺
|
781652-57-1
|
UNC926
|
UNC-926
|
1184136-10-4
|
BZAD-01
|
BZAD01
|
305339-41-7
|
TCN 201
|
TCN-201
|
852918-02-6
|
NE 10790
|
NE 10790
|
152831-36-2
|
1(2H)-Pyridineacetamide, N-[4-(aminocarbonyl)-3-fluorophenyl]-4-[5-chloro-2-[4-(trifluoromethyl)-1H-1,2,3-triazol-1-yl]phenyl]-α-ethyl-5-methoxy-2-oxo-, (αS)-
|
ASUNDEXIAN
|
2064121-65-7
|
SR9009
|
SR9009
|
1379686-30-2
|
SGC707
|
N-6-异喹啉基-N'-[2-氧代-2-(1-吡咯烷基)乙基]脲
|
1687736-54-4
|
FLT3-IN-3
|
SAN50900
|
2229050-90-0
|
Benzoic acid, 3-[2-[(2-fluorophenyl)amino]-5-oxazolyl]-
|
3-(2-((2-氟苯基)氨基)恶唑-5-基)苯甲酸
|
2375281-44-8
|
RU-302
|
RU-302 是一种非选择性的TAM 抑制剂,阻断 TAM Ig1 胞外域和 Gas6 Lg 结构域之间的界面。RU-302 用低微摩尔 IC50 有效阻断 Gas6 诱导的 Axl 受体活化,并有效抑制肺癌肿瘤的生长。
|
1182129-77-6
|
SBI-0206965
|
SBI0206965; SBI-0206965; SBI 0206965.
|
1884220-36-3
|
ATOLIHZIXHZSBA-BTSKBWHGSA-N
|
ATOLIHZIXHZSBA-BTSKBWHGSA-N
|
1312547-19-5
|
CNX-500
|
CNX-500
|
1202758-21-1
|
PXS 4728A
|
PXS 4728A
|
1478364-68-9
|
3-Piperidinecarboxylic acid, 1-[(2R)-2-[[4-(2-chloro-4-fluorophenyl)-2-oxo-2H-1-benzopyran-7-yl]oxy]-1-oxopropyl]-, (3S)-
|
化合物IMT1B
|
2304621-06-3
|
5-Phenyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide
|
5-苯基-1,2,5-噻二唑烷-3-酮 1,1-二氧化物
|
612530-44-6
|
3-Isoxazolecarboxamide, N-[1-[[2,4-bis(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-5-(2-furanyl)-
|
N-(1-(2,4-双(三氟甲基)苄基)-1H-吡唑-4-基)-5-(呋喃-2-基)异恶唑-3-甲酰胺
|
2323027-38-7
|
MT-802
|
MT-802
|
2231744-29-7
|
FLT3-IN-4
|
FLT3-IN-4
|
2304799-09-3
|
ml390
|
2029049-79-2
|
2029049-79-2
|
Ro 5-3335
|
化合物RO 5-3335
|
30195-30-3
|
GSK620
|
GSK620
|
2088410-46-0
|
6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 9-chloro-5,11-dihydro-5-propyl-
|
化合物BI-0115
|
4929-23-1
|
3-(3-Methoxyphenyl)-2-Methyl-N-(2-(thiazol-4-yl)-1H-benzo[d]iMidazol-5-yl)propanaMide hydrochloride
|
RY785
|
1393748-80-5
|
4-Methoxy-3-methylphenyl piperidin-1-yl sulphone, 2-Methyl-4-[(piperidin-1-yl)sulphonyl]anisole
|
4-Methoxy-3-methylphenyl piperidin-1-yl sulphone, 2-Methyl-4-[(piperidin-1-yl)sulphonyl]anisole
|
457961-34-1
|
6-Quinolinecarboxamide, 1-acetyl-4-[(5-chloro-2-pyrimidinyl)amino]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)-
|
化合物I-BET567
|
1887237-54-8
|
2-Propen-1-one, 1-[6-[(4R)-4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]hept-2-yl]-
|
JDQ-443
|
2653994-08-0
|
COUMESTROL
|
考迈斯托醇
|
479-13-0
|
CC-90010
|
CC-90010
|
1706738-98-8
|
MRK 560
|
MRK 560
|
677772-84-8
|
TAK-041
|
1929519-13-0
|
1929519-13-0
|
GCN2IB
|
GCN2IB
|
2183470-12-2
|
Ethyl 4-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzene Sulfonamide Carbamate
|
4-[2-(5-氯-2-甲氧基苯甲酰胺)-乙基]-苯磺酰胺基-甲酸乙酯
|
14511-59-2
|
Methanone, [2-(ethylsulfonyl)phenyl][(2S)-4-(6-fluoro-2-benzothiazolyl)-2-methyl-1-piperazinyl]-
|
化合物ARN19702
|
1971937-18-4
|
3-Amino-6-methoxy-N-[(2S)-3,3,3-trifluoro-2-hydroxy-2-methylpropyl]-5-(trifluoromethyl)-2-pyridinecarboxamide
|
3-氨基-6-甲氧基-N-[(2S)-3,3,3-三氟-2-羟基-2-甲基丙基]-5-(三氟甲基)-2-吡啶甲酰胺
|
1334546-77-8
|
Acetamide, 2-[3-[6-ethoxy-4-[[4-(1H-pyrazol-4-yl)phenyl]amino]-2-quinazolinyl]phenoxy]-N-(1-methylethyl)-
|
KL11743
|
1369452-53-8
|
4-(4,4-DIMETHYL-3-(6-(3-(OXAZOL-2-YL)PROPYL)PYRIDIN-3-YL)-5-OXO-2-THIOXOIMIDAZOLIDIN-1-YL)-3-FLUORO-2-(TRIFLUOROMETHYL)BENZONITRILE
|
GNF179
|
1261114-01-5
|
2-[2-Oxo-2-(2,2,4-trimethyl-3,4-dihydroquinolin-1(2H)-yl)ethyl]-1H-isoindole-1,3(2H)-dione
|
2-[2-氧代-2-(2,2,4-三甲基-3,4-二氢-2H-喹啉-1-基)-乙基]-异吲哚-1,3-二酮
|
332382-54-4
|
Ethanone, 1-[6-(3-chloro-4-hydroxyphenyl)-4-[[4-(diethylamino)cyclohexyl]amino]-3-quinolinyl]-
|
化合物 OTS447
|
1356943-67-3
|
2BAct(eIF2B activator 2BAct)
|
2BAct(eIF2B activator 2BAct)
|
2143542-28-1
|
GSK3186899
|
GSK3186899
|
1972617-87-0
|
DCC3014
|
DCC3014
|
1628606-05-2
|
4-(1-(2-amino-5-chloropyrimidin-4-yl)-2-(thiaol-2-yl)but-30-yn-2-ol
|
4-(1-(2-氨基-5-氯嘧啶-4-基)-2-(噻唑-2-基)-3-丁炔-2-醇
|
1202764-53-1
|
8-Quinolinecarbonitrile, 5-[(3R,5S)-3-amino-5-(trifluoromethyl)-1-piperidinyl]-
|
化合物ENPATORAN
|
2101938-42-3
|